Skip to main content
. 2015 Nov 11;2015(11):CD000491. doi: 10.1002/14651858.CD000491.pub3

Olsen 1989.

Methods Randomized controlled trial. No description of method for generation and concealment of treatment. Providers and pregnant women were not blinded. It was unclear whether the following criteria were met: blinding of outcome assessment, measurement of contamination of control group, assessment of co‐interventions, any deviation from protocol. Informed consent was obtained. No description of sample size or power calculation.
Participants 41 women enrolled in study. Setting: out‐patient clinic in Denmark. Inclusion criteria: pregnant women < 36 weeks estimated gestational age; confirmed asymptomatic bacteriuria with 2 consecutive urine cultures of bacterial count ≧ 100,000 colonies/mL urine; urine culture was sensitive to sulfamethizole. Exclusion criteria: signs of urinary tract infection; chronic disease of the genitourinary tract; history of more than 2 urinary tract infections in previous 12 months; threatening preterm labour > 26 weeks estimated gestational age; allergy to sulfonamides; antibiotic therapy for any reason within 3 weeks prior to study.
Interventions Experimental group: sulfamethizole 2 g x single dose.
 Control group: sulfamethizole 1 g twice daily x 6 days.
Outcomes Clinical outcomes: medication side effects.
 Laboratory outcomes: 'no cure', recurrence of asymptomatic bacteriuria.
Notes Type of healthcare provider: not described.
 Attrition bias: no women lost from experimental group 0/15; 2/26 (8%) women lost to follow‐up from control group.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not mentioned.
Allocation concealment (selection bias) Unclear risk Not mentioned.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 2 dropouts in the longer treatment arm.
Selective reporting (reporting bias) Unclear risk Not mentioned.
Other bias Unclear risk Lack of information in text to assess other sources of bias.
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Not blinded.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not mentioned.